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Hepatitis C virus p7 protein is a 63 amino acid polytopic protein with two transmembrane domains (TMDs) and
one of the prime targets for anti HCV drug development. A bio-inspired modeling pathway is used to generate
plausible computational models of the two TMDs forming the monomeric protein model. A flexible region
between Leu-13 and Gly-15 is identified for TMD11-32 and a region around Gly-46 to Trp-48 for TMD236-58.
Mutations of the tyrosine residues in TMD236-58 into phenylalanine and serine are simulated to identify their role in
shaping TMD2. Lowest energy structures of the two TMDs connected with the loop residues are used for a posing
study in which small molecule drugs BIT225, amantadine, rimantadine and NN-DNJ, are identified to bind to the loop
region. BIT225 is identified to interact with the backbone of the functionally important residues Arg-35 and Trp-36.
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Computational methods have grown to a stage where they
can be used to build small proteins or at least certain parts
of larger proteins, with respectably good results. Software
has been developed which allows small sized proteins to
be ‘built’ with high resolution (Rohl et al. 2004a; Rohl
et al. 2004b; Kim et al. 2004; Kaufmann et al. 2010). Buil-
ding assemblies of small membrane proteins, approaches
have been adopted which include a combination of
molecular dynamics simulations and docking protocols in
various ways (Bowie 1997; Kukol & Arkin 1999; Kerr et al.
1996; Forrest et al. 2000; Cordes et al. 2001; Bowie 2005;
Patargias et al. 2006; Psachoulia et al. 2008; Krüger &
Fischer 2009; Park et al. 2012). A major obstacle, is to
assemble proteins with oligomeric TMD topology. Sim-
plified, but nevertheless bio-inspired routes have to be de-
fined while assembling the proteins using a computational
approach (Hsu & Fischer 2011).
The routes of assembly are guided by the knowledge of
how membrane proteins are inserted or ‘folded’ into the
lipid membrane. Membrane proteins are translated at the
endoplasmic reticulum with the help of translocons
(Johnson & van Waes 1999; Rapoport et al. 2004; Cheng* Correspondence: wfischer@ym.edu.tw
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in any medium, provided the original work is p& Gilmore 2006). The translocons are membrane span-
ning proteins which enable the primary sequence of a
membrane protein to be folded into the secondary struc-
ture within the hydrophobic environment of the lipid
membrane. The topology of the respective membrane
protein is generated according to the information encoded
in its primary sequence (von Heijne 1988; Hessa et al.
2005; Fink et al. 2012). The protein is then finally released
into the lipid bilayer. The ‘monomeric unit’ is the protein,
which needs to be assembled further into the quaternary
fold. Within the lipid membrane, the fold of a helical motif
is adopted by the membrane protein prior to any consecu-
tive steps like assembly or integration of co-factors (Popot
& Engelman 1990; Engelman et al. 2003). Therefore, once
the secondary structure is formed, the protein remains in
this fold.
Viral channel forming proteins (Fischer & Sansom 2002;
Gonzales & Carrasco 2003; Fischer & Krüger 2009; Nieva
et al. 2012) are candidate proteins which can be built
along these considerations using computational tech-
niques (Krüger & Fischer 2009; Hsu & Fischer 2011). Viral
channel forming proteins are found as bitopic and poly-
topic membrane proteins with up to three TMDs (Hsu &
Fischer 2011; Fischer & Krüger 2009; Wang et al. 2010).
What they all have in common, is their existence as
homo-oligomers with a minimum number of four mo-
nomeric units in order to be totally functional. Theirn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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strate gradients across the lipid bilayer. However, the func-
tion within the infectivity cycle of the individual viruses
still remains mostly to be discovered.
Being one of the viral channel forming proteins,
encoded by HCV, p7 is built along the outlined com-
putational road. The genome of HCV is expressed as a
large polyprotein which is cleaved by proteases into the
array of individual proteins posttranslational. The poly-
topic p7 protein is located at the border between the
structural protein E2 and the following non-structural
proteins (Lin et al. 1994). With its 63 amino acids, it has
been suggested to have two TMDs (Patargias et al. 2006;
Carrère-Kremer et al. 2002). Channel activity of the pro-
tein has been reported (Pavlovic et al. 2003; Premkumar
et al. 2004; Chew et al. 2009; Griffin et al.; 2003; Clarke
et al. 2006), as well as the effect of potential drugs on its
channel activity (Pavlovic et al. 2003; Premkumar et al.
2004; Griffin et al. 2003; Steinmann et al. 2007a). The
role of the protein within the infectivity cycle is pro-
posed to be similar to M2 of influenza A in alternating
the pH gradient across lipid membranes (Griffin 2009).
A helical TM motif is confirmed by NMR spectros-
copy for a peptide corresponding to the second TMD
(Cook & Opella 2010) and a hair-pin structure for a full
length protein (Cook & Opella 2011). Detailed NMR ex-
periments identify TMD1 consisting of two helical parts
including the first 15 residues (Cook & Opella 2011;
Montserret et al. 2010), as well as TMD2 (Cook &
Opella 2011). The oligomeric state of p7 is suggested to
be hexameric based on electron microscopic data
(Griffin et al. 2003; Luik et al. 2009), with a potential to
form heptameric assemblies as well (Clarke et al. 2006).
It is most likely, that there is a strong strain specific
aspect to assembly and drug sensitivity (StGelais et al.
2009). In a NMR spectroscopic study an all atom hexa-
meric bundle structure is reported for the first time
(OuYang et al. 2013). Computational methods have been
done to generate a hexamer (Patargias et al. 2006). Con-
ductance studies with liposome based essays of a set of
mutant p7 reveal a concerted action of all structural
elements (StGelais et al. 2007). The TMDs and the basic
loop are important for the proper functioning of the
channel.
It is assumed that the individual TMDs envision a
short period of conformational equilibration within the
lipid environment prior to assembling into the oligomer.
Along this bio-inspired pathway, structural integrity of
the individual TMDs of p7 is evaluated using molecular
dynamic (MD) simulations in a fully hydrated lipid
bilayer. The sequence of the TMDs used, is based on a
bioinformatics approach (Patargias et al. 2006). A series
of mutations have been done in TMD2 to evaluate the
role of Tyr-42 in the fold of helix.Materials and methods
The sequence of the TMDs of p7 was taken from the
HCV genotype 1a, H77 strain (Pavlovic et al. 2003):
ALENLVILNA10 ASLAGTHGLV20 SFLVFFCFAW30
YLKGRWVPGA40 VYAFYGMWPL50 LLLLALPQR60
AYA. The following systems have been used in this
study: TMD110-32, TMD11-32, and TMD236-58, ML (mono-
mer p7 with loop, residues 10–57). The assembled mono-
mer, TMD1 and TMD2 without a loop (no loop), is
named ‘MNL’.
The following mutations in TMD2 were generated:
TMD236-58Y42/45F, TMD236-58Y42/45S, and TMD236-58F44Y.
The transmembrane domains TMD1 and TMD2 were
generated as ideal helices using the MOE software package
(Molecular operating environment, www.chemcomp.com).
MD simulations
Lipid bilayer patches were generated from 16:1–18:1
Diester PC, 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phos-
phocholine (POPC) molecules on the basis of the pa-
rameters of (Chandrasekhar et al. 2003) as reported earlier
(Krüger & Fischer 2008). The lipid system, which included
128 lipid and 3655 water molecules was due to a 70-ns
MD simulation. For simulations of the p7 monomer, four
of these lipid patches were combined to generate a larger
patch of 288 lipid molecules and 8748 water molecules.
The larger patch was equilibrated for 50 ns.
MD simulation of the systems, reported in the present
study, were carried out with GROMACS 4.0.7, using
Gromos96 (ffG45a3) force field. The temperature of the
peptide, lipid, and the water molecules were separately
coupled to a Berendsen thermostat at 310K with a coup-
ling time of 0.1 ps. For simulating the individual TMDs, a
fully isotropic pressure coupling was applied with a coup-
ling time of 1.0 ps and a compressibility 4.5e-5 bar-1. The
monomer was simulated with a semi isotropic pressure
coupling scheme. Long range electrostatics had been cal-
culated using the particle-mesh Ewald (PME) algorithm
with grid dimensions of 0.12 nm and interpolation order
4. Lennard-Jones and short-range Coulomb interactions
were cut off at 1.4 and 1nm, respectively.
Each one of the single helices was individually embed-
ded into the POPC bilayer system. Lipids which over-
lapped with the helix were removed and finally, the patch
resulted in 122 lipids (6344 atoms). After hydrating
the system with 3655 water molecules (10965 atoms), it
underwent steps of minimization (5000 steps of steepest
decent and 5000 steps of conjugated gradient) and equili-
bration for a total of 7.9 ns. Equilibration was achieved by
gradually increasing the temperature from 100 K to 200 K
and after that, to 310 K, whilst keeping the peptide fully
restrained with k = 1000 kJ mol-1 nm-2. The first two sim-
ulations (100 K and 200 K) were run for 200 ps, the last
simulation (310 K) was run for 1.5 ns. Holding the system
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the peptide, were released in 4 steps (k = 500 kJ mol-1 nm-2,
k = 250 kJ mol-1 nm-2, k = 100 kJ mol-1 nm-2, and k = 25 kJ
mol-1 nm-2), running each of the steps for 1.5 ns. The un-
constrained systems were submitted to production runs of
50 ns. The p7 monomer was embedded in a patch of 276
lipids (14352 atoms) and hydrated with 8746 water mole-
cules (26238 atoms). As soon as the loop was included, two
additional chloride ions were added to compensate charges
resulting from the residues (Lys-33 and Arg-35) within the
loop. The simulated boxes consist of 276 lipids and 8744
water molecules.
The root mean square fluctuation (RMSF) of Cα atoms
was calculated from data derived from the last 20 ns of
the 50 ns-simulations. The tilt and kink values were mea-
sured over the center of mass from the Cα atoms of resi-
dues 5–8, 11–14 and 17–21, as well as 1–4, 12–15 and
29–32 for TMD1-32 (here residue number according to
the sequence used in the simulation software) and also
averaged over the frames of the last 20 ns of the simula-
tion. The kink angle is the angle set by the two ends of the
helices. Any kink would result in an angle lower than 180°.
Assembly of the monomers
The starting structure of TMDs for assembly was the aver-
age structure over the backbone atoms of the 50 ns MD
simulations. Rotational and translational motions were re-
moved by fitting the peptide structure of each time frame
to the starting structure. The program g_covar from the
GROMACS-3.3.1 and 4.0.5 packages was used for the cal-
culations (Krüger & Fischer 2009).
The derived helices were assembled using a protocol
reported earlier (Krüger & Fischer 2009; Hsu & Fischer
2011). The two helical backbone structures were aligned
symmetrically towards a central axis. To sample the whole
conformational space of the bundles, each of the degrees
of freedom were varied stepwise: (i) inter helical distance
in steps of 0.25 Å covering 9 to 15 Å; (ii) rotational angles
around the helical axis in steps of 5° covering 360°; (iii) tilt
in steps of 2° covering −36 to +36°. The side chains were
linked to the backbone, for each position. The side chain
conformation was chosen to be the most likely one for a
given backbone position and referenced in the MOE
library. A short minimization (15 steps of steepest decent)
followed the linking (Chen et al. 2011). In this way,
2985984 conformers of the p7 MNL were generated and
stored in a data base for further analysis. The potential en-
ergy of each conformer was evaluated, according to the
united-atom AMBER94 force field. The structure with the
lowest energy is taken for further analysis. To mimic the
bilayer environment, the dielectric constant was set to 2.
The simulations were run on a DELL i7-930 worksta-
tion and a 28 core Opteron based computer cluster with
Infiniband interconnects.Plots and pictures were made with VMD-1.8.7 and
MOE-2008.10 and 2010.10.
Docking approach
FlexX 2.0 (www.biosolveit.com) was used to dock small
molecule ligands to the proteins. Flexible ring conforma-
tions were computed by CORINA, a 3D structure generator
interfaced with FlexX. Two atoms, from each protein, were
selected to define the center of a sphere with a radius of
20 Å. All atoms of the proteins were situated within the
spheres. The drugs, BIT225 (N-(5-(1-methyl-1H-pyrazol-
4-yl) naphthalene-2-carbonyl) guanidine), amantadine (1-
adamantylamine) and rimantadine (1-(1-adamantyl)
ethanamine) were obtained from the PubChem compound
library (pubchem.ncbi.nlm.nih.gov). NN-DNJ (N-nonyl-
deoxynojirimycin) was generated and minimized with the
MMFF94x using the MOE building software. The scoring
of the FlexX module is based on a geometry-based scoring
(Böhm 1994), calculating estimated free energies (Rarey
et al. 1996). The HYDE module of LeadIT 2.1.2 (www.
biosolveit.com) was used to derive a rescoring based on the
Gibbs-Helmholtz equations describing hydration and
desolvation of the individual atoms in the ligand-protein
complex (Schneider et al. 2011). The energies values for the
two terms, hydration and desolvation, were calculated in re-
spect to hydrogen bonding, hydrophobic interactions and
desolvation energies, as well as further calibrated using
octanol/water partitioning data. The protocol also includes
two optimization procedures, which optimize the hydrogen
bond network between the ligand-protein complex and a
numerical optimization algorithm.
Results
MD simulations of individual wild type and mutant TMDs
The TMDs of p7 (see also Patargias et al. (2006)) are ge-
nerated as ideal helices, individually embedded into a fully
hydrated lipid bilayer and run for 50 ns (TMD110-32 and
TMD236-58) and 100 ns (TMD11-32). The root mean
square deviation (RMSD) values of the Cα atoms of all
TMDs investigated, level off after a short rise within the
first few nanoseconds (Figure 1A). The RMSF calculations
reveal a w-like pattern for all TMDs (Figure 1B, I – III).
At the N-termini of wild type TMD1 and TMD2, RMSF
values are higher than at the C-termini (Figure 1B, I). In
TMD1, Ser-21 and Phe-22 exhibit maximal RMSF values.
Large fluctuations are found for a Gly-46/Met-47/Trp-48
motif of TMD2. Residues within the head group region
and at the interface of the hydrophobic core of the mem-
brane hardly fluctuate. RMSF values for TMD11-32 identify
a maximum fluctuation for residue Ala-14 and smaller
fluctuations for residues Val-6 and Ile-7 (Figure 1B, III).
A stretch of mutant TMD2-Y42/45F from residue
Phe-44 to Leu-50, including the GMW motif, adopts
values above 0.1 nm (Figure 1B, II, green). On both sides
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like the ones found for WT TMD2. RMSF values for
TMD2-Y42/45S follow the pattern of TMD2 (Figure 1B, II,
orange), whilst TMD2-F44Yshows amore extended stretch
of fluctuating residues, almost similar to TMD110-32
(Figure 1B, II, blue).
The w-shape of the RMSF curve reflects the mobility
of the lipid bilayer in its central core. Replacing hydro-
philic residues by others (TM2-Y42/45S) or increasing
the hydrophilic stretch by another residue (TM2-
F44Y), does not alter the dynamics of the residues. A
lengthening of the hydrophobic stretch in the center
of the TMD (TM2-Y42/45F) goes parallel with increased
dynamics of the residues within the hydrophobic core of
the membrane.
DSSP analysis (Dictionary of Secondary Structure of
Proteins) reveals that the GMW motif of TMD2 adopts
a turn like structure (Additional file 1: Figure S1A). The
analysis of TMD11-32 indicates two types of kinetics: (i) a
stepwise development of turn motifs emerging from
Ala-14 via His-17/Gly-18 towards Ser-21/Phe-22/Leu-23
and (ii) from Ala-14 in a single step towards Val-6/Ile-7
(Additional file 1: Figure S1B).Figure 1 Root mean square deviation (RMSD) and fluctuation (RMSF)
of the Cα atoms of the single TMDs embedded in a fully hydrated lipid bil
respectively (AI); values for the mutants are shown in blue (TMD236-58F44Y)
those for TMD11-32 are shown in (AIII). The respective RMSF values are show
according to the sequence number in the protein (see Materials and MethAveraged kink for TMD110-32 (156.2 ± 9.4)° is lower than
for TMD236-58 (142.6 ± 7.3)° (Table 1), but the tilt (14.1 ±
5.5)° is higher than for TMD236-58 (8.9 ± 4.2)°. Lengthening
the hydrophobic core of TMD2 as in TMD2-Y42/45F re-
sults in a large kink of the helix (153.0 ± 11.3)° but lower
tilt towards the membrane normal ((7.8 ± 3.9)°). Increasing
hydrophilicity within TMD2 (TMD2-F44Y) results in very
large kink (136.1 ± 21.0)° and tilt angles (20.8 ± 4.9)°.
Whilst decreasing the size of already existing hydrophilic
residues within TMD2 (TMD2-Y42/45S) rather affects the
kink (162.0 ± 8.1)° than the tilt (8.5 ± 3.5)° angle, when
compared with TMD236-58. The large kink of TMD11-32,
(147.5 ± 9.1)°, is due to the conformational changes to-
wards its N terminal side. The averaged tilt angle adopts a
value of (20.1 ± 4.2)° and with this it is, on average, larger
than the tilt of TMD110-32.
Visible inspection of the simulation data reveals that
TMD110-32 remains straight in the lipid bilayer and
TMD2 kinks and tilts away from the membrane normal
in a 50 ns simulation (Figure 2A, left and right). Water
molecules are found in close proximity to the hydroxyl
group of Y-42/45 for TMD2 (Figure 2B, I). Mutating an
additional tyrosine into the N terminal side of TMD2data of the single TMDs. RMSD (A) and RMSF plots (B I, II, III)
ayer. Values for TMD110-32 and TMD236-58 are shown in black and red,
, green (TMD236-58Y42F/Y45F) and orange (TMD236-58Y42S/Y45S) (AII),
n in the same color scheme as mentioned. Residue numbers
ods).
Table 1 Averaged kink and tilt angles in degree of the
individual TMDs and the TMDs of the monomer
Kink [°] Tilt [°]
Individual TMDs
TMD110-32 156.2 ± 9.4 14.1 ± 5.5
TMD236-58 142.6 ± 7.3 8.9 ± 4.2
TMD11-32 147.5 ± 9.1 20.1 ± 4.2
TMD2-F44Y 136.1 ± 21.0 20.8 ± 4.9
TMD2-Y42/45S 162.0 ± 8.1 8.5 ± 3.5
TMD2-Y42/45F 153.0 ± 11.3 7.8 ± 3.9
Monomer
MNL
TMD1 161.7 ± 5.6 24.4 ± 6.9
TMD2 143.1 ± 8.4 28.8 ± 11.8
ML
TMD1 159.2 ± 4.3 12.8 ± 4.3
TMD2 159.6 ± 5.7 18.6 ± 2.9
The values represent averages taken over the entire length of each of
the simulations.
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rosines with the phospholipid head group region and
leads to penetration of water molecules into this region.
These dynamics are not observed for TMD2-Y42/45S
and TMD2-Y42/45F (Figure 2B, II and III). TMD11-32
adopts a strong bend structure with a complex kink/
bend motif starting from Ala-14 towards the N terminal
side (Figure 2D). The motif is driven by integration of
the N terminal side into the phospholipid head group re-
gion. During the 100 ns simulation, a ‘groove’ develops,
in which the backbone is exposed to the environment
due to accumulation of alanines and a glycine at one
side of the helix (Figure 2D, lower two panels,
highlighted with a bend bar).Assembly of the p7 monomer (TMD110-32 and TMD236-58)
and MD simulations
Assembling TMD1 and TMD2 reveals a monomer, MNL,
with the lowest energy at 452.5 kcal/mol, a minimum
distance of 11.6 Å, a tilt of −8° and a narrow energy val-
ley for the rotational angles of both TMDs (Figure 2C
and Additional file 2: Figure S2). The monomer assem-
bles enabling Leu-19 (10) and Leu-23(14) of TMD1, as
well as Leu-50, -52 and -53 of TMD2, to intercalate,
forming a hydrophobic pocket (Figure 2C, left). Trypto-
phans at both ends of the helices (Trp-30 (TMD1) and
Trp-36 (TMD2)) cause the two helices to stay apart
giving the overall assembly a conical shape (Figure 2C,
left and right). The widening towards the linking region
is also supported by the bulky valines of TMD2, Val-37
and −41.In 150 ns MD simulations of the monomer, either
without the linking loop or in the presence of it, show
RMSD values of around 0.25 nm. During the course of
the simulation, the RMSD of the monomer without loop
also reaches values of around 0.3 nm.
The RMSF values for TMD1 in MNL ‘oscillate’ be-
tween 0.2 and 0.1 nm, especially on the C terminal side
(Figure 3, I). The ‘amplitude’ decreases over the course of
the simulation. This pattern does not affect the helicity of
the TMD (Additional file 3: Figure S3, I). For TMD2, high
RMSF values (around and above 0.2 nm) are calculated
for the first five residues on the N terminal side. The
values level around 0.1 nm towards the C-terminal side.
For ML, all RMSF values level around 0.1 except for the
first 5 residues on the N-terminus and the last two resi-
dues on the C-terminus (Figure 3, II). Throughout the
simulation, the fluctuation of the residues at the C-
terminal side of TMD1 increases, reaching almost 0.2 nm
for Lys-33 and Gly-34. The value for Arg-35 is calculated
to be about 0.1 nm. Similar to MNL, TMD2 develops a w-
like pattern of its RMSF values, identifying a dynamic
hydrophobic core region.
Following the trajectories of the MD simulations, the
two TMDs of MNL adopt a slightly higher tilted structure
(24.4° and 28.8° for TMD1 and TMD2, respectively) than
the TMDs in ML (12.8° and 18.6° for TMD1 and TMD2,
respectively; Figure 4 and Table 1). In MNL, kink angles of
the TMDs adopt values of 161.7° for TMD1 and 143.1°,
for TMD2 they are almost the same (around 159°) for ML.
Consequently, the loop induces conformational con-
straints, resulting in a moderate and almost similar tilt of
both TMDs. At the current stage of the simulation of the
monomer, the tyrosines of TMD2 move into the hydro-
phobic core region of the lipid bilayer and attract water
molecules towards the end of the simulation (Figure 4,
lower panel).
Docking approach with the p7 monomer
Docking the small molecule drug BIT225 to MNL, taken
from the MD simulation at 0 ns, shows the first binding
site (−16.7 kJ/mol, see Table 2) to be located towards the
side of the loop (data not shown). A second site is found
at the C terminal side of TMD1 (−13.7 kJ/mol) and a
third site at the C terminal side of TMD2 (−12.6 kJ/
mol). For the structure at 150 ns, the top three sites are
changed so that the first site is at the N terminal side
(−17.7 kJ/mol), the second at the C terminal side of
TMD1 (−16.2 kJ/mol), and the third site (−13.9 kJ/mol)
at the N terminal side of TMD2. Interactions of the sites
are driven by hydrogen bonding of the guanidinium
group with the amide bond of the protein backbone. Re-
fined calculations using HYDE, leaves the sequence for
the structure at 0 ns (see Table 2): for the 150 ns struc-
tures though, the best pose becomes the third in rank
Figure 2 Graphical representation of the TMDs. Snapshots of TMD110-32 (A, left column) and TMD236-58 (A, right column) are shown at 0 ns
and 50 ns. The individual mutant TMDs (left), (middle), (right) are presented with structures at 50 ns (B). The lowest energy structures of the
assembled monomers (assembled with MOE) without (left) and with loop (right) are outlined (C). The left monomer highlights the leusines (light blue).
The backbone is shown in yellow for all structures. TMD11-32 is shown at 0 ns and 100 ns, as well as in different perspectives and with some
residues indicated (D). Histidine (red), phenylalanines (green), tyrosines (dark blue), tryptophans (magenta), methionine (pink), valines (white),
glycines (black), leusines (light blue) and serines (orange) are marked in stick modus. Water molecules are drawn in blue, using a ball-stick modus.
Lipids are omitted for clarity. The bar in (D) indicates the backbone exposed side of the helix to the membrane.
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HYDE (ScoreH)) (Table 2). For ML, the best pose
remains faced towards the loop for both structures (the
one at 0 and the one at 150 ns) and the second site
remains faced towards the C-terminal side of TMD1(Figure 5A). A third site at the C-terminus of TMD2,
found for the structure taken from 0 ns, is not identified
after 150 ns. The best poses with MNL show that the
pyrazol group establishes hydrogen bonds with the side
chain of Arg-35 and the backbone nitrogen of Trp-36.
Figure 3 Root mean square deviation (RMSD) and fluctuation (RMSF) data of the monomers. RMSD plots of the simulations of the
monomers without (red) and with (black) loop (A). The respective time resolved RMSF data of the simulations without (I) and with (II) loop are
shown for frames at 50 ns (black), 100 ns (red) and 150 ns (green) (B). Residue numbers according to the sequence number in the protein (see
Materials and Methods).
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Figure 4 Graphical representation of the monomers. Snapshots of the 150 ns simulations of the monomers without (top row) and with loop
(botom row) separately embedded into hydrated lipid bilayers. The backbone is shown in yellow. Histidine (red), phenylalanines (green), tyrosines
(dark blue), serine (orange) are shown in stick modus. Water molecules are drawn in blue using a ball-stick modus. Lipids are omitted for clarity.
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as low as approximately −20 kJ/mol for the best sites at
the 0 ns (−21.6/-16.5 kJ/mol) and 150 ns structures
(−23.8/-27.0 kJ/mol). Refined calculations do not replace
the best poses.
The sites of amantadine at different structures of MNL
are identified to be with the N-terminus of TMD2 for
the best pose of the structure at 0 ns, but found at the N
(TMD1)/C-terminal sides (TMD2) in the structure at
150 ns, forming hydrogen bonds with the backbone
(data not shown). In the presence of the loop (ML),
amantadine also poses at the site of the loop (Figure 5B).
With ML, amantadine forms hydrogen bonds with the
backbone carbonyls of residues from TMD1 (Cys-27,
Tyr-31, Leu-32 (structure at 0 ns) and Leu-32, Lys-33
(structure at 150 ns). The best pose of binding of
rimantadine with MNL is identified to be via its amino
group, with the backbone carbonyl of either Trp-48
(0 ns structure) or the hydroxyl group of the side chain
of Ser-12 (150 ns structure) (data not shown). The best
pose for rimantadine in ML is with the backbone of Phe-
26, which is within the TMD (structure at 0 ns) and the
backbone of Trp-36, which is within the loop of the
structure at 150 ns (Figure 5C). The second best pose
with the 150 ns structure is found to be towards the C-
terminal side of TMD2. In all cases, the binding affinities
for amantadine and rimantadine are in the range of −10
kJ/mol to 0 kJ/mol (Table 2). For amantadine docked to
MNL, the order reverses position 2 and 3 for rimantadine
(0 and 150 ns structure). For amantadine docked to ML,
the order reverses for the structure at 0 ns. At this sec-
ond site (first in respect to HYDE), the interaction isdriven by hydrogen bonding of the amino group of aman-
tadine with the backbone carbonyls of His-17 and the hy-
droxyl group in the side chain of Ser-12 (data not shown).
For the ML structure at 150 ns with rimantadine, the third
pose becomes the best one when recalculating the ener-
gies with HYDE. In this pose, hydrogen binding of the
amino group of rimantadine with the carbonyl backbone
of Tyr-33 together with hydrophobic interactions between
adamantan and the aromatic rings of Tyr-42 and −45
(data not shown) is found.
Docking of NN-DNJ onto MNL identifies the best pose
between the two ends of the TMDs towards the side of
the loop (data not shown). Backbone carbonyls of Tyr-42,
Ala-43 and Gly-46 form hydrogen bonds via the hydroxyl
groups of the iminosugar moiety with the structure at 0
ns. The hydrogen bonding of Tyr-42 serves as an acceptor
for two off the hydroxyl groups of the ligand. The car-
bonyl backbone of His-17, as well as the backbone NH
groups of Gly-15 and Leu-19 both serve as hydrogen
acceptors and donors, respectively, in TMD1 at 150 ns.
Based on the refined calculation of the binding affinities,
the best poses based on FlexX of −2.0/-8.2 kJ/mol (0 ns
structure) and −0.9/-8.0 kJ/mol (150 ns structure)) be-
come the second best for both structures, when recalcu-
lating with HYDE (−1.1/-21.9 kJ/mol (0 ns) and −0.3/-39.3
kJ/mol (150 ns)). The large values of −21.9 and −39.3 kJ/
mol are due to the large number of hydrogen bonds (each
hydroxyl group forms a hydrogen bond with carbonyl
backbones and side chains in combinations with favorable
hydrophobic interactions (data not shown). The best pose
of NN-DNJ with ML is in the loop region via hydrogen
bonds of the hydroxyl group with carbonyl backbone group
Table 2 Calculated poses (FlexX 2.0) and estimated binding affinity calculated with HYDE module (FlexX) for the drugs
BIT225, amantadine, rimantadine and NN-DNJ
Compound Time No loop Loop TMD11-32
ScoreF ScoreH ScoreF ScoreH ScoreF ScoreH
[kJ/mol] [kJ/mol] [kJ/mol] [kJ/mol] [kJ/mol] [kJ/mol]
BIT225 0 −16.7 −21.7 −21.6 −16.5
−13.7 −15.9 −16.8 1.4
−12.6 −6.7 −13.9 −9.8
150 −17.7 −14.4 −23.8 −27.0 −14.3 −8.5
−16.2 −16.4 −20.2 −14.4 −12.1 −13.4
−13.9 −15.9 −11.1 −8.6
ssAmatadine 0 1.4 −2.7 −5.0 −9.3
−0.5 −10.8
150 −2.3 −8.5 −3.7 −5.7 −2.0 −9.9
−1.6 0.6 −3.0 −3.8 −0.5 −8.0
Rimantadine 0 −3.7 −2.4 −4.8 −7.9
−3.1 −10.0 −4.2 −2.4
−1.6 −8.1 −2.6 −7.7
150 −2.8 −15.6 −4.7 −10.1 −3.8 −15.9
−1.9 −7.0 −4.6 −7.2 −1.2 −12.6
−1.6 −15.0 −3.8 −12.4 −0.9 −7.4
NN-DNJ 0 −2.0 −8.2 −7.8 −16.1
−1.1 −21.9
150 −0.9 −8.0 −7.1 −8.9 2.5 −21.3
−0.3 −39.3 −4.1 −14.6 2.9 −20.7
4.8 −11.2
The energies of the best poses of each cluster are shown for the respective structures at 0 ns and 150 ns (Time). All values are given in kJ/mol. ‘ScoreF’ refers to
the values from FlexX 2.0, ‘scoreH’ to those from HYDE.
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addition, one hydroxyl group ofNN-DNJ forms a hydrogen
bond with the side chain of Arg-35. The binding affinities
are calculated to be −7.8/-16.1 kJ/mol. In the 150 ns
ML structure, a maximum of hydrogen bond partners are
suggested: carbonyl backbone groups of Phe-28, Ala-29,
Trp-30 and Leu-32, as well as side chain of Arg-35 for the
best pose (−7.1/-8.9 kJ/mol). In addition to that, the
aliphatic chain is surrounded by hydrophobic side chains of
Ala-29 and Tyr-31. Refined calculations put the second
pose into the first rank (−4.1/-14.6 kJ/mol). Similarly, in this
pose, hydrogen bonds are formed with the backbone car-
bonyls of Gly-34 and Try-36. The aliphatic tail is embedded
into a hydrophobic pocket of Leu-32, Lys-33, Gly-34 and
Trp-36 (data not shown). NN-DNJ is the only ligand
which interacts with carbonyl backbones of the residues
of TMD11-32 (150 ns structure) closer to the N terminal
side: Ala-10, -11 and Gly-15. The alkyl chain adopts van
der Waals interactions with small residues such as Ala-
14, Gly-15/18.
All small molecules mentioned, show best binding sites
with TMD11-32 towards the C-terminal side and at its end:no pose at the extended N-terminal side is identified at
this stage. Both types of calculations of the binding affin-
ities leave all best poses in the same order (Table 2).
Docking indicates that the C-terminal side and the loop
region impose a high potential drug binding site. Con-
sidering ML and all binding affinities for ranking the
compounds, the following sequence can be suggested:
BIT225 <NN-DNJ < Amantadine ≈ Rimantadine.
Discussion
Bio-inspired pathway translated into feasible
computational steps
Membrane proteins are manufactured at the site of the
endoplasmic membrane via interplay between ribosome
and translocon. The protein is released into the membrane
through a side passage of the translocon. The stoichiometry
of the overall reaction is: one ribosome per translocon gen-
erates one protein. Consequently, the proteins generated
along this pathway are the monomers which have to oligo-
merize within the lipid membrane in order to generate a
functional ion channel. It is assumed, that between manu-
facturing the monomer and theassembly into an oligomer,
Figure 5 Small molecule drug docking to the monomers. Docking of small molecule drugs to the monomer with loop taken from 150 ns
MD simulation: BIT225 (A), amantadine (B), rimantadine (C) and NN-DNJ (D). For each drug the best pose is shown in orange, the second best
pose in blue and the third best pose in green.
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accordance with the respective environmental conditions.
In case of p7, the protein needs to be cleaved from the
polyprotein precursor. Finally, the respective monomer
have to assemble with other p7 monomers to form a pore.
With this in mind, the modeling strategy is chosen to
(i) generate the individual helices of p7 and relax the
structures briefly via MD simulations in a fully hydrated
lipid bilayer, (ii) assemble the resulting two helices into a
monomer using a docking approach, which mimics the
lipid environment, and (iii) relax the monomer further via
MD simulations.
The effect of selected structures on a docking approach
is evaluated through choosing monomer structures at 0 ns
and 100 ns.
Simulations of TMD1 with two different lengths
The role of the individual helical segments within TMD1
can be evaluated by simulating the domain with two diffe-
rent lengths. TMD110-32 is chosen based on a consensus de-
rived from several secondary structure prediction programs(SSPPs). The longer helix TMD11-32 includes the N-
terminal part which also has been predicted by only one
of the SSPPs, e.g. SPLIT4 (Patargias et al. 2006), but is
now identified by NMR studies (Cook & Opella 2011;
Montserret et al. 2010). There is consensus among the
two simulations in as much as the weakly fluctuating
Ser-21/Phe-22 of the shorter TMD110-32 is mobile in
simulations of TMD11-32. Due to the extended helix
which remains in the motif during 100 ns MD simula-
tions, the most flexible part is moved one helical turn
further towards the N terminal side, spiking around
Ala-14. This leaves the residues towards the C-terminal
side from Ala-14 onwards gradually declining in their
mobility. Consequently, the resulting assembled struc-
tures with the shorter TMD1 and TMD2 are a reliable
motif for the monomer and the respective bundles.
This reasonable choice of the shorter TMDs is sup-
ported further by the feature, that the backbone of
TMD11-32 is exposed to the environment due to the
accumulating alanines (Ala-10/-11/-14) and glycines
(Gly-15) on one side of the helix. The assembled models
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exposed part to approach the backbone of TMD1 closely
to form the tepee-like structure.
According to the RMSF data, the ‘naked’ section of
TMD11-32 allows some flexibility within this region, mak-
ing it susceptible to entropic or enthalpy driven effects.
Therefore, it is possible that this region is an important
section for gating related conformational changes.
Analysis of the DSSP plot of TMD11-32 reveals stepwise
conformational changes which almost ‘jump’ over one hel-
ical turn to the next leaving the original one back in a helical
conformation. These ‘jumps’ seem to follow n+1 and n+2
helical turns and imply a ‘self-healing’ of the helix.
Simulations with mutants and their impact on the
structure
Due to the tyrosines 42 and 45, TMD2 experiences a con-
siderable kink combined with a moderate tilt. The kink
angle is increased when mutating the hydrophobic residue
Phe-44 into tyrosine. The increase of the kink occurs due
to the ‘snorkeling’ of the tyrosines for the hydrophilic head
group region and the aqueous phase. The snorkeling effect
(usually used in context with lysines (Strandberg & Killian
2003)), is accompanied by a further insertion of the rest of
the part of the helix which is directed towards the other
leaflet into the hydrophobic part of the membrane. Re-
moving the hydroxy groups, as in TM2-Y42/45F, reduces
the snorkeling and with it the kink and tilt. Smaller hydro-
philic residues, such as serines, do not have a big impact
on either the kink or the tilt angle of the helix. Serine
rather forms hydrogen bonds with the backbone to com-
pensate unfavorable interactions with the hydrophobic en-
vironment of the lipid membrane, than to interact with
the lipid head groups and water molecules (after a while).
It is concluded, that hydrophilic residues, accumulated on
one side of a TM helix, lead to attract water molecules to
compensate for hydrogen bonding and charges, and a
tearing further into the hydrophobic core region of its
other side. The consequence is a considerable kink or
bend of the helix. In the monomer, the bending of TMD2
is preserved, when running the monomer with a linker.
If further bending is hampered, the hydrophilic re-
sidues could alternatively force water molecules into the
lipid bilayer. Other studies show, that water is being
dragged into the membrane when a helix containing ar-
ginine residues is positioned in the membrane (Dorairaj
& Allen 2007). More generally, a hydrophilic helix, fully
inserted in the lipid membrane, completely hydrates it-
self during a 100 ns MD simulation (Hong et al. 2012).
Comparison of the structural model with data from NMR
spectroscopy
Two monomeric structures (Cook & Opella 2011;
Montserret et al. 2010) and a bundle structure (OuYanget al. 2013) have been reported which are derived from
NMR spectroscopic experiments.
Solid state NMR spectroscopic analysis of p7 (genotype
J4, 1b) expressed as a fusion construct in Escherichia coli,
purified and reconstituted into DHPC (1,2-diheptanoyl-
sn-glycero-3-phosphocholine) let four helical segments to
be suggested within the lipid bilayer (Cook & Opella
2011). The four segments can be distinguished by their
mobility. NMR data allow the statement, that segments
from residue 5 – 15 (TMD1) and from 41 – 48 (TMD2)
are more mobile than segments 17 – 27 (TMD1) and 49 –
57 (TMD2). The latter two segments adopt measurable
tilts of 25° and 10°, respectively. In the present study,
TMD110-32 includes residues 10 – 15 of the reported ex-
perimental study. The w-shaped RMSF plots, calculated
from MD simulations of the individual helices, support
the experimental results of 4 segments separated by higher
fluctuating residues (Figure 1B, I). The ‘separating’ resi-
dues are around Val-20/Ser-21/Phe-22 for TMD110-32,
Ala-14 for TMD11-32 and the GMW-motif for TMD2.
Whilst the residues in TMD110-32 are shifted by one hel-
ical turn towards the C-terminus compared to the NMR
data, the residues in TMD11-32 and TMD236-58 almost
match the residues found in the NMR experiments. The
separating residues in TMD2 are conserved in the simula-
tions of the monomer with and without loop (Figure 3B).
Simulations of the monomer with loop reveals fluctua-
tions around Pro-38 within the N-terminal part of TMD2.
This is similar to high fluctuations found in the simula-
tions of MNL indicating higher mobility of this segment in
accordance with the NMR findings. According to the
MD simulations, TMD2 seems to adopt a larger tilt than
TMD1 with a stronger kink of TMD2 than TMD1.
In another study, a computational model based on com-
bined CD and NMR spectra is proposed (Montserret et al.
2010). Synthesized peptides, corresponding to full length
protein and the individual TMDs of p7 protein (sequence
based on HCV-J of genotype 1b), have been reconstituted
into detergents such as 100 mM dodecylphosphocholine
(DPC) or sodium dodecyl sulphate (SDS), or dissolved in
TFE/H2O mixtures. The structural models of the individ-
ual TMDs have been subject of protein-protein docking
using GRAMM program (Tovchigrechko & Vakser 2006)
to generate a monomer. The assembled TMDs have con-
sequently been linked by four amino acids modeling a
hairpin motive using VMD software. The spectra support
the motif of two helical segments towards the N-terminal
side and a shorter helix at the C-terminal side followed by
a mobile segment. Both of the sections are separated by a
hairpin like motif. The computational model of the mono-
mer has been run for 40 ns MD simulation (NAMD,
CHARMM27) in a fully hydrated lipid bilayer. From the
MD simulations in this study, a flexible region of Gly-15
to Gly-18 is suggested, which matches with higher RMSF
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the monomer in the present study (Figure 3BI,II). In this
study, the flexible region is positioned within one helix
turn (Leu-13 to Gly-15) towards the N terminal side
(Figure 1B, IV). The staging motif of alternating aromatic
residues from TMD1 and TMD2 to define the TMD1-
loop-TMD2 region (Montserret et al. 2010) has not been
found in the present study.
Taken together, the described computational model of
monomeric p7 matches the experimental data in several
aspects. Thus, the working protocol described in this
study, is a worthwhile tool to assess structural features
of membrane proteins. Simulation on TMD11-32 fits into
the experimental findings. Consequently, a region of
residues with short side chains N-terminal from His-17
is flexible and exposes the backbone, potentially for gat-
ing kinetics.
Comparison of TMD2-NMR with TMD236-58 reveals
that the NMR structure is comparable within the error
margins in respect to kink and tilt angles. The simi-
larity holds especially the C terminal side, despite the
additional residues on either side of TMD2-NMR as
well as their unwinding. This unwinding obscures the
identification of the w-shape of the RMSF values, since
the fluctuation of the additional five helices result in
high values.
Binding site in the loop region
The sensitivity of p7 towards inhibitors has been reported
to be strain specific (StGelais et al. 2009; Griffin et al. 2008).
Bilayer recording data report on a blockage of p7 by NN-
DNJ which is more effective than blockage by amantadine
and rimantadine (Steinmann et al. 2007b). Also, strain spe-
cific tests in cell culture reveal activity of these compounds
(Griffin et al. 2008). Resistant mutations, observed upon
adminstration of the two typs of drugs affect residues (i)
Leu-20 (into L20F) induced by adamantanes and (ii) Phe-25
(into F25A) induced by iminosugars (Foster et al. 2011).
These sites are within TMD1. Application of a docking ap-
proach using Autodock, on a heptameric bundle and a
monomer, support a potential binding site within the TM
region of p7. The poly leusine motif (Leu-50 to Leu-55) has
been identified to be sensitive to amantadine (Cook &
Opella 2010). In the present docking study, the site for
amantadine interaction with p7 does not match these
experimental findings (Cook & Opella 2010; StGelais et al.
2009; Griffin et al. 2008).
In a previous computational docking approach of the
hexameric p7 bundle, a binding site for amantadine via
hydrogen bonding with the carbonyl group of Ser-21 has
been proposed (Patargias et al. 2006). With the binding
residues presented in this study, amantadine is very close
to the binding of Ser-21, as reported earlier. The discrep-
ancy may rather occur due to the use of the monomer inthis study, than the bundle as in the afore mentioned
study (Patargias et al. 2006).
The prime site of interaction for all small molecule
drugs investigated, including BIT225, in this study, is the
loop region by forming hydrogen bonds with carbonyl
backbones. In case of the iminosugars, this site in the
loop region is possibly less favorable than for BIT225,
even though a number of hydrogen bonds can be
formed. The disfavor may be because of the aliphatic
chain of NN-DNJ, which has to cope with the unfavor-
able position. The chain could interact with hydrophobic
pockets in the protein, though this comes with some en-
tropic costs. For amantadine and rimantadines, the same
situation may hold with some minor advantages in as
much as the hydrophobic part of these molecules may
not get many restrictions in conformational flexibility
upon binding. In contrast to e.g. NN-DNJ, amantadine
and rimantadine can form fewer numbers of hydrogen
bonds, what then compensates the entropic costs arising
for NN-DNJ upon binding. BIT225 seems as the most
favorable molecule, in respect of entropic costs. Experi-
ments with mutants in this region would be necessary to
proof the proposed mechanism of binding. What do the
results mean for a potential drug? The potent drug
should interact with sensitive amino acids, preferentially
with its backbone, in the loop region.
What are the biological consequences of the inter-
action with the water exposed sites of the protein? It has
been shown, that residues in the loop region, Lys-33 and
Arg-35, are important for the functioning of the protein
(Steinmann et al. 2007b). Binding of any drug via inter-
acting with the backbone of the protein would hamper
the dynamics of the loop and with it, possibly, the free
energy involved in the mechanism of function. In the
specific case of BIT225, the interaction is indeed identi-
fied to be with the backbone of the highly important res-
idues Arg-35. This may explain the successful antiviral
activity of this compound compared to amantadine and
one of its derivatives.
Conclusions
Computational structural modeling of biological mole-
cules, for which experimentally derived date is rare, is a
challenging task. Two ‘key stones’ are at hand when
starting the endeavor, (i) the membrane protein to be
discussed is inserted into the lipid membrane via the
translocon complex, and (ii) the two stage folding model
of membrane proteins, which suggests, that the second-
ary structure is generated prior to any further assembly
process. According to the present study, the side chain
residues are further responsible for the ‘fine tuning’ of
the secondary structure. The tyrosines of TMD2 in p7
are important residues defining the shape of the helix
and with it the structure of the monomer.
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environment making this part of the protein an ideal tar-
get site. The investigated small molecule drugs in this
study indicates, that the interaction could be via hydro-
gen bonding with main chain atoms of sensitive amino
acids in the loop.
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Additional file 1: Figure S1. DSSP plots of the individual TMDs
embedded into hydrated lipid bilayers reporting a 50 ns MD simulation:
TMD110-32 (I), TMD236-58 (II), TMD236-58F44Y (III), TMD236-58Y42F/Y45F (IV),
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